Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey
- 10 September 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 14 (10)
Abstract
Background: Critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) are highly vulnerable to infections, including invasive fungal diseases and antifungal agents are frequently prescribed. Little is known about antifungal usage in PICUs across Europe. Methods: A multinational 3-month weekly point-prevalence study for measuring antifungal drug use was organized. Eigtheen PICUs (16 hospitals) in 10 countries in the European region participated. All patients hospitalized in the participating PICUs and receiving systemic antifungals were included. Information about ward demographics was collected once; weekly ward and patient data were collected prospectively for the 12-week study period and entered in REDCap database. Results: Among 18 PICUs, 8 (44%) followed prophylactic practices for targeted group of patients, 7/18 (39%) had an antifungal stewardship program and the majority (16/18, 89%) had the capacity of biomarker utilization (16/16 galactomannan, 13/16 beta-D-glucan, and 9/16 pan-fungal PCR). One hundred one courses in equal number of patients were recorded; 14 for patients aged <3 month, 87 for patients ≥3 month. Malignancy was the most common underlying condition among patients aged ≥3 month (29%) followed by surgery/trauma (25%), whereas all patients <3 month had undergone a recent surgery. Indication for antifungal prescribing was prophylaxis in 38% and treatment in 62% [empirical (57%), preemptive (13%), and targeted (30%)]. Fluconazole was the most common agent both for prophylaxis and treatment, whereas liposomal amphotericin B was the most frequent agent for targeted treatment. The majority (63%) of patients on prophylaxis were oncology or transplant patients. Common reasons for empirical and targeted treatment were persistent fever/other signs of infections in high-risk patients (61%) and Candida infections (100%), respectively. For targeted treatment, the most frequent pathogens were Candida albicans (37%) and Candida parapsilosis (32%). Conclusions: Most antifungal prescriptions across European PICUs were for treatment. Fluconazole was the most frequently prescribed antifungal. These surveillance data can guide antifungal stewardship strategies in PICUs.Keywords
Funding Information
- Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER (JR22/00044)
This publication has 31 references indexed in Scilit:
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASMThe Lancet Infectious Diseases, 2025
- Correction to: Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and AdolescentsClinical Infectious Diseases, 2023
- Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care UnitsCurrent Treatment Options in Infectious Diseases, 2022
- Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research ConsortiumThe Journal of Infectious Diseases, 2020
- Invasive Candida Infections in a Pediatric Intensive Care Unit in Turkey: Evaluation of an 11-Year PeriodJournal of Pediatric Intensive Care, 2019
- Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence surveyJournal of Global Antimicrobial Resistance, 2018
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2015
- Invasive candidiasis in pediatric intensive care in Greece: a nationwide studyIntensive Care Medicine, 2013
- Treatment and timing in invasive mould diseaseJournal of Antimicrobial Chemotherapy, 2010
- Risk Factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for PreventionClinical Infectious Diseases, 2010